Arrowhead Pharmaceuticals (ARWR.MX) Q4 2024 Earnings

26NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-28.09
-21.37
-14.64
-7.92

Details

Expected EPS
-23.142871361999998
Actual EPS
-28.0913984
Surprise EPS
-4.95
Surprise Percent
+21.38%

Description

Arrowhead Pharmaceuticals (ARWR.MX) has reported earnings of -28.0913984 per share for Q4 2024.

0 Comments

Share your thoughts